These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Naftopidil, a selective {alpha}1-adrenoceptor antagonist, suppresses human prostate tumor growth by altering interactions between tumor cells and stroma. Hori Y, Ishii K, Kanda H, Iwamoto Y, Nishikawa K, Soga N, Kise H, Arima K, Sugimura Y. Cancer Prev Res (Phila); 2011 Jan; 4(1):87-96. PubMed ID: 21205739 [Abstract] [Full Text] [Related]
5. Patrinia scabiosaefolia inhibits colorectal cancer growth through suppression of tumor angiogenesis. Chen L, Liu L, Ye L, Shen A, Chen Y, Sferra TJ, Peng J. Oncol Rep; 2013 Sep; 30(3):1439-43. PubMed ID: 23820929 [Abstract] [Full Text] [Related]
8. Inhibition of MMP-9 using a pyrrole-imidazole polyamide reduces cell invasion in renal cell carcinoma. Sato A, Nagase H, Obinata D, Fujiwara K, Fukuda N, Soma M, Yamaguchi K, Kawata N, Takahashi S. Int J Oncol; 2013 Nov; 43(5):1441-6. PubMed ID: 23969530 [Abstract] [Full Text] [Related]
9. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice. Uchida T, Gao JP, Wang C, Satoh T, Itoh I, Muramoto M, Hyodo T, Irie A, Akahoshi T, Jiang SX, Kameya T, Baba S. Mol Urol; 2001 Nov; 5(2):71-8. PubMed ID: 11690551 [Abstract] [Full Text] [Related]
11. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells]. Li CY, Yao AM, Chang XN, Guo YH, Xu R. Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958 [Abstract] [Full Text] [Related]
18. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas. Hemmerlein B, Galuschka L, Putzer N, Zischkau S, Heuser M. Histopathology; 2004 Dec; 45(6):603-11. PubMed ID: 15569051 [Abstract] [Full Text] [Related]
19. Prostate growth inhibition by subtype-selective alpha(1)-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia. Kojima Y, Sasaki S, Oda N, Koshimizu TA, Hayashi Y, Kiniwa M, Tsujimoto G, Kohri K. Prostate; 2009 Oct 01; 69(14):1521-8. PubMed ID: 19544328 [Abstract] [Full Text] [Related]